Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Silence Therapeutics plc (SLN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
19.95+1.45 (+7.84%)
At close: 03:39PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 12/13/2021
Current
9/30/202112/31/2020
Market Cap (intraday)
654.08M628.03M583.56M
Enterprise Value
553.25M519.19M514.97M
Trailing P/E
N/AN/AN/A
Forward P/E
N/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/A
Price/Sales (ttm)
47.9645.11308.98
Price/Book (mrq)
34.2219.4149.48
Enterprise Value/Revenue
48.76164.51-611.60
Enterprise Value/EBITDA
-11.70-43.71-138.36

Trading Information

Stock Price History

Beta (5Y Monthly) 1.07
52-Week Change 3-15.11%
S&P500 52-Week Change 314.07%
52 Week High 335.00
52 Week Low 318.20
50-Day Moving Average 323.24
200-Day Moving Average 324.01

Share Statistics

Avg Vol (3 month) 345.21k
Avg Vol (10 day) 39.57k
Shares Outstanding 529.93M
Implied Shares Outstanding 6N/A
Float 811.74M
% Held by Insiders 11.43%
% Held by Institutions 16.53%
Shares Short (Dec 30, 2021) 45.67k
Short Ratio (Dec 30, 2021) 40.05
Short % of Float (Dec 30, 2021) 4N/A
Short % of Shares Outstanding (Dec 30, 2021) 40.02%
Shares Short (prior month Nov 29, 2021) 42.6k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Sep 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-368.17%

Management Effectiveness

Return on Assets (ttm)-29.22%
Return on Equity (ttm)-333.73%

Income Statement

Revenue (ttm)11.35M
Revenue Per Share (ttm)0.39
Quarterly Revenue Growth (yoy)58.80%
Gross Profit (ttm)1.72M
EBITDA -41.41M
Net Income Avi to Common (ttm)-42.42M
Diluted EPS (ttm)-1.98
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)76.47M
Total Cash Per Share (mrq)2.56
Total Debt (mrq)131k
Total Debt/Equity (mrq)0.80
Current Ratio (mrq)4.52
Book Value Per Share (mrq)0.55

Cash Flow Statement

Operating Cash Flow (ttm)3.6M
Levered Free Cash Flow (ttm)3.27M
Advertisement
Advertisement